You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lung Cancer Non Small Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

    Recruiting
    • Lung Cancer Non-small Cell Stage IV
      • Athens, Greece
        Hellenic Cooperative Oncology Group
      Nov 14, 2022

      Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

      Active, not recruiting
      • Lung Cancer, Non-small Cell
      • hypofractionated radiation therapy
      • Nanjing, Jiangsu, China
        Jiangsu Cancer Hospital
      Mar 13, 2023

      Double-dose Furmonertinib in Treatment of Slow

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • (no location specified)
      Oct 31, 2023

      NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +2 more
      • Nintedanib, gefitinib, erlotinib, afatinib
      • (no location specified)
      Oct 2, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

        Not yet recruiting
        • Stage II-IIIB(N2) Non-small Cell Lung Cancer
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Oct 26, 2023

        NSCLC Trial in Shanghai

        Not yet recruiting
        • Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Jul 20, 2023

          NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

          Recruiting
          • Non-small Cell Lung Cancer
          • +3 more
          • Yangzhou, Jiangsu, China
            People's hospital of northern jiangsu
          Sep 26, 2023

          Locally Advanced Non Small Cell Lung Cancer Patients in Brazil

          Completed
          • Lung Cancer, Non-small Cell
            • Salvador, BA, Brazil
            • +10 more
            Jan 5, 2023

            Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB, Lung Cancer Non-Small Cell Stage III Trial in

            Not yet recruiting
            • Lung Cancer, Nonsmall Cell, Stage IIIA
            • +4 more
            • E-health ecosystem of stepped psychosocial care
            • Usual psychosocial care
            • L'Hospitalet De Llobregat, Catalunya, Spain
              Institut Català d'Oncologia
            Aug 9, 2022

            NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • Tirelizumab；Chemotherapy monotherapy
            • (no location specified)
            Jul 27, 2023

            Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

            Not yet recruiting
            • Metastatic Lung Non-Small Cell Carcinoma
            • +2 more
            • Cetuximab
            • +2 more
            • Sacramento, California
              University of California Davis Comprehensive Cancer Center
            Oct 2, 2023

            NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

            Not yet recruiting
            • Non-small Cell Lung Cancer
            • Iowa City, Iowa
              University of Iowa
            Oct 10, 2023

            NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

            Not yet recruiting
            • Non-Small Cell Lung Cancer
            • (no location specified)
            Sep 6, 2023

            T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

            Not yet recruiting
            • Non-small Cell Lung Cancer Metastatic
              • (no location specified)
              Sep 13, 2023

              NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

              Not yet recruiting
              • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
              • (no location specified)
              Aug 27, 2023

              NSCLC Trial in Guangzhou (BL-M07D1)

              Not yet recruiting
              • Non-small Cell Lung Cancer
              • Guangzhou, Guangdong, China
                Sun Yat-sen University Cancer Center
              Nov 1, 2023

              Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

              Recruiting
              • Untreated Advanced Non-small Cell Lung Cancer
              • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
              • Fuzhou, Fujian, China
                Fujian Cancer Hospital
              Nov 13, 2023

              Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

              Recruiting
              • Non Small Cell Lung Cancer
              • +2 more
              • Port Saint Lucie, Florida
              • +1 more
              Aug 11, 2023

              Extensive Stage Small Cell Lung Cancer

              Not yet recruiting
              • Extensive-stage Small-cell Lung Cancer
                • Changsha, Hunan, China
                  Hunan Cancer hospital
                Aug 6, 2023

                Identify Resected Non-small-cell Lung Cancer With High Risk of

                Recruiting
                • Non-small Cell Lung Cancer Stage IIIA
                • Resected non small cell lung cancer
                • Toulouse, France
                  Julien MAZIERES
                Feb 8, 2023

                NSCLC Trial in Beijing

                Recruiting
                • NSCLC
                  • Beijing, China
                    Yuyan Wang
                  Oct 10, 2023

                  Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

                  Recruiting
                  • Nonsmall Cell Lung Cancer
                  • HS-10365 capsules
                  • Shanghai, Shanghai, China
                    Shanghai Chest Hospital
                  Nov 22, 2023

                  Integrative Multi-Omics Testing for Immunotherapy Response in

                  Recruiting
                  • Lung Cancer
                    • Guangzhou, Guangdong, China
                      Nanfang hospital
                    Jun 29, 2023